Trials / Recruiting
RecruitingNCT05319158
The Effect of the Movement Imitation Therapy in Preterm (MIT-PB) in Motor Behavior's Quality.
The Effect of the Movement Imitation Therapy for Preterm Babies (MIT-PB) on Motor Behavior Quality. Quasi-experimental Design.
- Status
- Recruiting
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 36 (estimated)
- Sponsor
- Institut d'Investigació Biomèdica de Girona Dr. Josep Trueta · Academic / Other
- Sex
- All
- Age
- 22 Weeks – 32 Weeks
- Healthy volunteers
- Not accepted
Summary
This study aims to assess the effect of a parent-administered intervention program based on MIT-PB in preterm with abnormal general movements during the preterm period. We will describe the short and long-term differences between infants exposed to MIT-PB and infants who follow current standard care.
Detailed description
The quasi-experimental design has been planned to assess the effect of a physiotherapy program carried out in neonatal intensive care and at home during the first months of life. Preterm babies born before 32 weeks gestational age (GA) and/or with less than 1500g showing an abnormal General Movement Assessment (GMA) at 34-36 weeks will be included. Standardized tests will be performed at baseline, at term, 44 weeks post-menstrual age (PMA), 54 weeks PMA, 6 months, and 12 months. A qualitative study has been designed to assess the physiotherapy performance and parents' experience. Three different Hospitals with similar care protocols and sizes will recruit the sample (n=36). The Intervention groups (n=18) will be located at Hospital Josep Trueta of Girona and Hospital Sant Joan de Déu and the control group (n=18) will be located at Hospital Parc Taulí of Sabadell (Barcelona).
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| OTHER | MIT-PB, movement imitation therapy for preterm. | The instant an infant showed CS or PR movements, the therapists (or a therapist and a parent) intervened by gently guiding the infants' limbs so as to maneuver and smoothen their movements, thereby imitating normal GM sequences as closely as possible, adding variability to the movement |
Timeline
- Start date
- 2022-04-04
- Primary completion
- 2026-03-31
- Completion
- 2027-03-31
- First posted
- 2022-04-08
- Last updated
- 2024-12-10
Locations
3 sites across 1 country: Spain
Source: ClinicalTrials.gov record NCT05319158. Inclusion in this directory is not an endorsement.